HEATHER BALL: Open Payments
NPI 1063661049 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 62 payments from 18 companies in 2025. Trend: 2023 $2,321 · 2024 $1,335 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $196 |
| Novo Nordisk Inc | 7 | $161 |
| ABBVIE INC. | 5 | $92 |
| Lilly USA, LLC | 5 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $77 |
| Amgen Inc. | 5 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Dexcom, Inc. | 2 | $72 |
| Janssen Pharmaceuticals, Inc | 4 | $67 |
| Merck Sharp & Dohme LLC | 2 | $58 |
Products named: NURTEC ODT, MOUNJARO, XIFAXAN, Ozempic, REXULTI, Dexcom G6 Transmitter, SPRAVATO, VRAYLAR.
Industry payments across VA — which companies pay providers there.
